Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
| Brand name | LISDEXAMFETAMINE DIMESYLATE |
| Generic name | LISDEXAMFETAMINE DIMESYLATE |
| Active ingredient(s) | LISDEXAMFETAMINE DIMESYLATE |
| Distributed by / for | Lannett Company, Inc., Philadelphia, PA 19136 |
| NDC | 0527-4664-37 |
| Full product label | Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37 |
| Recalling firm | Lannett Company Inc. |
| Distribution | Nationwide within the USA |
| Quantity | 8544 bottles |
| Recall initiated | 2025-08-11 |
| Report date | 2025-09-03 |
| Recall completed | 2026-06-24 |
| Recall number | D-0599-2025 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Seymour IN United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗